A large cohort study including patients with sepsis and cirrhosis (25% with septic shock) found that despite a higher mortality in patients who received albumin, after adjustment for time-dependent administration and baseline confounders, albumin was associated with reduced 28-day mortality [29]. Here, ALB is linked to Cirrhosis.